257 related articles for article (PubMed ID: 25818930)
1. Valsartan Promoting Atherosclerotic Plaque Stabilization by Upregulating Renalase: A Potential-Related Gene of Atherosclerosis.
Zhou M; Ma C; Liu W; Liu H; Wang N; Kang Q; Li P
J Cardiovasc Pharmacol Ther; 2015 Sep; 20(5):509-19. PubMed ID: 25818930
[TBL] [Abstract][Full Text] [Related]
2. Deletion of the angiotensin II type 1a receptor prevents atherosclerotic plaque rupture in apolipoprotein E-/- mice.
Aono J; Suzuki J; Iwai M; Horiuchi M; Nagai T; Nishimura K; Inoue K; Ogimoto A; Okayama H; Higaki J
Arterioscler Thromb Vasc Biol; 2012 Jun; 32(6):1453-9. PubMed ID: 22460554
[TBL] [Abstract][Full Text] [Related]
3. Neprilysin Inhibitor-Angiotensin II Receptor Blocker Combination Therapy (Sacubitril/valsartan) Suppresses Atherosclerotic Plaque Formation and Inhibits Inflammation in Apolipoprotein E- Deficient Mice.
Zhang H; Liu G; Zhou W; Zhang W; Wang K; Zhang J
Sci Rep; 2019 Apr; 9(1):6509. PubMed ID: 31019233
[TBL] [Abstract][Full Text] [Related]
4. Effects of Renin-Angiotensin System Inhibitors on Renal Expression of Renalase in Sprague-Dawley Rats Fed With High Salt Diet.
Wang Y; Xie BQ; Gao WH; Yan DY; Zheng WL; Lv YB; Cao YM; Hu JW; Yuan ZY; Mu JJ
Kidney Blood Press Res; 2015; 40(6):605-13. PubMed ID: 26619289
[TBL] [Abstract][Full Text] [Related]
5. Suxiaojiuxin pill enhances atherosclerotic plaque stability by modulating the MMPs/TIMPs balance in ApoE-deficient mice.
Zhang J; Zhuang P; Lu Z; Zhang M; Zhang T; Zhang Y; Wang J; Liu D; Tong Y
J Cardiovasc Pharmacol; 2014 Aug; 64(2):120-6. PubMed ID: 24621651
[TBL] [Abstract][Full Text] [Related]
6. Valsartan Attenuates Atherosclerosis via Upregulating the Th2 Immune Response in Prolonged Angiotensin II-Treated ApoE(-/-) Mice.
Meng K; Zeng Q; Lu Q; Lin Y; Wu B; Yu K; Dong Z; Zhang J; Chai M; Liu Y; Ji Q; Zhou Y
Mol Med; 2015 Feb; 21(1):143-53. PubMed ID: 25685964
[TBL] [Abstract][Full Text] [Related]
7. [Impact of rosuvastatin on atherosclerosis lesions in apolipoprotein E knockout mice].
Luo RN; Tao LJ; Zhou J; Wang R; Lu MM; Fu X
Zhonghua Xin Xue Guan Bing Za Zhi; 2011 Aug; 39(8):743-8. PubMed ID: 22169423
[TBL] [Abstract][Full Text] [Related]
8. ATRQβ-001 vaccine prevents atherosclerosis in apolipoprotein E-null mice.
Zhou Y; Wang S; Qiu Z; Song X; Pan Y; Hu X; Zhang H; Deng Y; Ding D; Wu H; Yang S; Wang M; Zhou Z; Liao Y; Chen X
J Hypertens; 2016 Mar; 34(3):474-85; discussion 485. PubMed ID: 26771341
[TBL] [Abstract][Full Text] [Related]
9. Deletion of angiotensin II type 2 receptor exaggerated atherosclerosis in apolipoprotein E-null mice.
Iwai M; Chen R; Li Z; Shiuchi T; Suzuki J; Ide A; Tsuda M; Okumura M; Min LJ; Mogi M; Horiuchi M
Circulation; 2005 Sep; 112(11):1636-43. PubMed ID: 16145000
[TBL] [Abstract][Full Text] [Related]
10. Angiotensin II induces extracellular matrix metalloproteinase inducer expression via an AT1R dependent pathway in aortic atherosclerotic plaque in apolipoprotein E knockout mice.
Yang LX; Yang ZH; Guo RW; Ye JS; Liu H
J Renin Angiotensin Aldosterone Syst; 2012 Mar; 13(1):67-75. PubMed ID: 22020146
[TBL] [Abstract][Full Text] [Related]
11. Angiotensin II Promotes Atherogenesis through upregulating the Expression of Connexin 43 in Dendritic Cells.
Nie W; Yan H; Li S; Zhu W; Fan F; Zhu J
Cell Mol Biol (Noisy-le-grand); 2015 Jul; 61(3):96-101. PubMed ID: 26255138
[TBL] [Abstract][Full Text] [Related]
12. Angiotensin-(1-7) dose-dependently inhibits atherosclerotic lesion formation and enhances plaque stability by targeting vascular cells.
Yang JM; Dong M; Meng X; Zhao YX; Yang XY; Liu XL; Hao PP; Li JJ; Wang XP; Zhang K; Gao F; Zhao XQ; Zhang MX; Zhang Y; Zhang C
Arterioscler Thromb Vasc Biol; 2013 Aug; 33(8):1978-85. PubMed ID: 23723368
[TBL] [Abstract][Full Text] [Related]
13. AT1 blockade attenuates atherosclerotic plaque destabilization accompanied by the suppression of cathepsin S activity in apoE-deficient mice.
Sasaki T; Kuzuya M; Nakamura K; Cheng XW; Hayashi T; Song H; Hu L; Okumura K; Murohara T; Iguchi A; Sato K
Atherosclerosis; 2010 Jun; 210(2):430-7. PubMed ID: 20079903
[TBL] [Abstract][Full Text] [Related]
14. Fluvastatin enhances the inhibitory effects of a selective AT1 receptor blocker, valsartan, on atherosclerosis.
Li Z; Iwai M; Wu L; Liu HW; Chen R; Jinno T; Suzuki J; Tsuda M; Gao XY; Okumura M; Cui TX; Horiuchi M
Hypertension; 2004 Nov; 44(5):758-63. PubMed ID: 15452025
[TBL] [Abstract][Full Text] [Related]
15. Diminazene Aceturate Stabilizes Atherosclerotic Plaque and Attenuates Hepatic Steatosis in apoE-Knockout Mice by Influencing Macrophages Polarization and Taurine Biosynthesis.
Stachowicz A; Wiśniewska A; Kuś K; Białas M; Łomnicka M; Totoń-Żurańska J; Kiepura A; Stachyra K; Suski M; Bujak-Giżycka B; Jawień J; Olszanecki R
Int J Mol Sci; 2021 May; 22(11):. PubMed ID: 34070749
[TBL] [Abstract][Full Text] [Related]
16. Endogenous activated angiotensin-(1-7) plays a protective effect against atherosclerotic plaques unstability in high fat diet fed ApoE knockout mice.
Yang J; Yang X; Meng X; Dong M; Guo T; Kong J; Zhang K; Zhang Y; Zhang C
Int J Cardiol; 2015 Apr; 184():645-652. PubMed ID: 25771230
[TBL] [Abstract][Full Text] [Related]
17. [Effects of some active ingredients of Chinese drugs for activating blood circulation and detoxicating on blood lipids and atherosclerotic plaque inflammatory reaction in ApoE-gene knockout mice].
Zhou MX; Xu H; Chen KJ
Zhongguo Zhong Xi Yi Jie He Za Zhi; 2008 Feb; 28(2):126-30. PubMed ID: 18386574
[TBL] [Abstract][Full Text] [Related]
18. Activation of Bone Marrow-Derived Cells Angiotensin (Ang) II Type 1 Receptor by Ang II Promotes Atherosclerotic Plaque Vulnerability.
Pellegrin M; Bouzourène K; Aubert JF; Nahimana A; Duchosal MA; Mazzolai L
Int J Mol Sci; 2018 Sep; 19(9):. PubMed ID: 30181481
[TBL] [Abstract][Full Text] [Related]
19. Urotensin II receptor knockout mice on an ApoE knockout background fed a high-fat diet exhibit an enhanced hyperlipidemic and atherosclerotic phenotype.
Bousette N; D'Orleans-Juste P; Kiss RS; You Z; Genest J; Al-Ramli W; Qureshi ST; Gramolini A; Behm D; Ohlstein EH; Harrison SM; Douglas SA; Giaid A
Circ Res; 2009 Sep; 105(7):686-95, 19 p following 695. PubMed ID: 19696412
[TBL] [Abstract][Full Text] [Related]
20. Hexim1 heterozygosity stabilizes atherosclerotic plaque and decreased steatosis in ApoE null mice fed atherogenic diet.
Dhar-Mascareno M; Rozenberg I; Iqbal J; Hussain MM; Beckles D; Mascareno E
Int J Biochem Cell Biol; 2017 Feb; 83():56-64. PubMed ID: 28013147
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
